About IVAL

Dear Colleague:

IVAL is proud to present our products and contract services to you that represent our past three decades of expertise in the application of in vitro experimental systems to evaluate drug absorption, metabolism, drug-drug interactions and drug toxicity.

Besides the “routine” in vitro ADME studies that are also offered by other contract research organizations, we have developed higher throughput screening assays to aid the selection of best drug candidates for during early phases of drug development: Organ-specific toxicity evaluation (e.g. hepatotoxicity; nephrotoxicity; neurotoxicity) using primary cells either as mono-cell type studies or as multiple organ co-cultures using our patented Integrated Discrete Multiple Organ Co-culture (IdMOC) experimental system; human hepatocyte P450 inhibition assays, and human hepatocyte P450 induction assays; as well as a comprehensive screening assay for adverse drug properties.

I will appreciate receiving feedback from you on our service offerings and our Ph.D. scientists will be more than happy to provide expert consultations and assistance to your technical questions. Please feel free to contact me by email at: lialbert@invitroadmet.com.

With my best regards,
Albert P. Li, Ph. D.
President and CEO
In Vitro ADMET Laboratories, LLC